RxDoctor Payments Data

Angela Meyer, MD

Family Medicine · Knoxville, TNNPI 1669413563

Payments from drug & device makers

$11,725in general payments, 2019–2025

Across 701 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • Amgen$1K
  • AbbVie$1K
  • Pfizer$911
  • Novo Nordisk$796
  • Boehringer Ingelheim$766
  • plus $5K from 44 others

What the payments were for

  • Food & beverage$11,62599%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,725 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$155,186
Medicare patients
264
Services billed
4,922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab45$78,231
EliquisApixaban68$72,993
JardianceEmpagliflozin72$58,751
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$51,280
XareltoRivaroxaban27$30,391
TrulicityDulaglutide16$22,377
OzempicSemaglutide14$15,762
Tresiba Flextouch U-200Insulin Degludec14$11,634
ShingrixVaricella-Zoster Ge/As01b/Pf45$10,230
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$9,850
Olmesartan Medoxomil428$6,943
Esomeprazole Magnesium155$5,067
SymbicortBudesonide/Formoterol Fumarate14$4,859
Levothyroxine Sodium612$4,499
Rosuvastatin Calcium543$4,045

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$1,146$78,23145 claims
PfizerEliquis$911$72,99368 claims
GSKTrelegy Ellipta, Shingrix$1,624$61,510103 claims
Boehringer IngelheimJardiance$766$58,75172 claims
Johnson & JohnsonXarelto$437$30,39127 claims
Lilly USA, LLCTrulicity$131$22,37716 claims
Novo NordiskOzempic$796$15,76214 claims
AstraZenecaBreztri Aerosphere, Symbicort$477$14,70926 claims
MerckJanumet$265$3,51412 claims
Sanofi-aventis U.S. LLCLantus$165$2,09912 claims
AbbVieSynthroid$1,142$1,00125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →